Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Biohaven Pharmaceuticals Inc.
Sponsor

Biohaven Pharmaceuticals Inc.

United States 215 Church Street, 06510-1803, United States

About the sponsor

Biohaven Pharmaceuticals Inc. is active in clinical research for Obsessive Compulsive Disorder, with studies centered on patients who have not responded adequately to standard SSRI and related antidepressant treatments.

  • Obsessive Compulsive Disorder
  • Treatment-resistant symptoms
  • Adjunctive therapy

The sponsor’s psychiatric research includes evaluation of symptom improvement and longer-term safety and tolerability in individuals living with persistent compulsive and intrusive symptoms.

About Specializations

Biohaven Pharmaceuticals Inc. runs clinical trials in conditions such as Anxiety disorder, Spinal muscular atrophy, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Anxiety disorder

Not recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Troriluzole
  • Sponsor:Biohaven Pharmaceuticals Inc.

Anxiety disorder

Not recruiting
InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Troriluzole
  • Sponsor:Biohaven Pharmaceuticals Inc.

Spinal muscular atrophy

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Taldefgrobep Alfa
  • Sponsor:Biohaven Pharmaceuticals Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.